StimScience Granted a Patent for Treatment of Traumatic Brain Injuries

StimScience is a startup company founded in 2017. It was recently highlighted in the Consumer Sleep Patent Forecast® for its announcement in April 2021 that it raised $6M in seed financing and is developing a consumer brain stimulation…

Cerenetex and Viz.ai Share a Goal, But Who Has The Patents?

Cerenetex is a startup company founded in 2018. Since strokes are a leading cause of disability and death, and affect over 15 million people worldwide, the company’s mission is to use artificial intelligence to diagnose large vessel…

Xenotherapeutics Enters the Sector With a Patent Application Related to Xenotransplantation

Xenotherapeutics is a clinical-stage biotechnology research and development company. The company is focused on developing personalized cells, tissues, and organs to provide regenerative medicine solutions. Specifically, the company is…

Will the Apple Watch 8 Include Blood Pressure Monitoring? The Patent Data Say Yes

Patent Forecast recently highlighted Fitbit for a patent granted in early December 2021. The patent related to an intelligent inflatable cuff used for arm-based blood pressure measurements. We predicted that Fitbit would soon integrate…

Insilico Makes History With Entirely AI Based Drug Discovery

One of the largest trends in biotechnology is the use of Artificial Intelligence in drug discovery. AI is able to analyze vast quantities of data, identify complex patterns, and generate predictions. Therefore, it is extremely useful for…

Patent Forecast Saw it First – Atolla Acquired

In January of 2020 Patent Forecast highlighted Atolla. The company uses machine learning to provide customers with custom skincare products. At the time, Patent Forecast recognized that the skincare category of the AI Biotech Patent…

LightForce Orthodontics Improves Old Technology to Find White Space in Sector

Over the last decade teeth-straightening clear aligners have greatly increased in popularity and accessibility. This is shown by the takeover of the Dental category of the AI Biotech Patent Forecast® by Align Technology, the manufacturer…

Smart Watches – What about DNA Watches?

DnaNudge is a British company that specializes in DNA testing. The company has 4 patent assets in the AI Biotech Patent Forecast®. The patent assets relate to the company’s main product, the DnaBean and band. To use the DnaBean, customers…

Select – Revolutionizing Body Composition But Missing Patents

Select Research is recognized as one of the world’s leading companies for 3D measuring of the human body. Most recently, the company has been using its 3D scanning capabilities to measure obesity and predict associated risks. The company’s…

Growing Portfolio + New Partnerships Could Equal Future Acquisition or Emerging Leader

Deep Bio was founded in 2015, with the mission of improving the reliability of diagnostics and decreasing the time it takes clinicians to reach diagnoses. Currently, the company is working with medical professionals to integrate artificial…

Retrace Labs Launches AI-Based Dental Management Network – Will Patents be Granted?

Retrace Labs, founded in 2016, is a start up company backed by Intel and SoftBank Group Corp. that has been working to grow its portfolio in the AI Biotech Patent Forecast®. In 2020, the company’s first 6 patent applications were…

Welldoc is Expanding – The Patent Data Can Tell Us Where

Welldoc is a healthcare company that develops solutions for managing chronic diseases. Its chronic care management platform uses AI to track and implement healthcare plans tailored to specific conditions such as diabetes, heart failure,…

Cleerly – Clearly a Company to Watch

Cleerly is a startup company, founded in 2017, whose mission is to create a new standard of care for heart disease. Its platform uses AI to assess Coronary CT Angiography images and identify, characterize, and quantify plaque build up to…

Whoop 4.0 – Invisible Wearables, Various Sensors, Improved Batteries – What about patents?

Whoop is a wearable device company geared towards athletes. The company has been highlighted in a recent insight for its role in the Consumer Sleep Technology Patent Forecast®, as it continues to develop sleep technology. It also currently…

Theator’s Intelligence Platform – A New Aspect of AI’s Future in Surgery

Theator Inc. is a startup company with a surgical intelligence platform that leverages AI and computer vision to analyze key moments of surgical procedures. The platform intelligently curates moments from surgeries for surgeons to review…

Revolutionary Advancements in Portable Ultrasound – The Patent Data Told us First

In recent years ultrasound has become increasingly portable, easy to use, and cost-efficient. It is also safer than other medical imaging modalities because it does not expose patients to ionizing radiation, and it can be used to diagnose…

The Race to Non-Invasive Glucose Monitoring – A New Competitor

In July 2021, Patent Forecast provided an overview of glucose monitoring and the major players racing to successfully monitor glucose with non-invasive methods. This week a new player entered this race with a patent application assigned to…

Dexcom and the Race to Non-Invasive Glucose Monitoring

Dexcom leads glucose monitoring in the AI Biotech Patent Forecast® with 48 patent assets as shown in the radian above. So far, the company’s main focus has been making its continuous glucose monitoring (CGM) systems compatible with major…

Flow Acquires Halo Neuro and its 28 Patent Assets – Now What?

Neuromodulation is technology that alters nerve activity by delivering electrical or chemical signals directly to a target area. Flow Neuroscience uses such technology to treat depression, which is associated with lower neural activity in…

BostonGene is Growing Quickly – How will Veracyte React?

BostonGene is a quickly growing biomedical software startup that uses its intelligent interactive platform to assist physicians in finding the most effective strategy for precision cancer therapy. This is done using the BostonGene Tumor…

Bardy Diagnostics, Preventice, and Biotelemetry Acquired – Who’s next?

In June 2020 Patent Forecast highlighted an up and coming company, Bardy Diagnostics. At the time, the company had 7 patent assets in the AI Biotech Patent Forecast® regarding its CAM patch, a wearable ECG monitor with improved long-term…

Veracyte Fills Holes in Patent Portfolio – Now Able to Detect 8 of the 10 Most Common Cancers

Veracyte has 24 patent assets in the AI Biotech Patent Forecast® radian relating to molecular profiling and algorithms used for diagnosing diseases and identifying biomarkers. The company’s most recent publication, filed in 2020,…

Google Restructures Its Health Division – Patent Data Will Predict The Next Steps

As Google restructures its health unit, patent activity will be key to predicting its future endeavors. This was previously shown when Patent Forecast® predicted Google’s acquisition of Fitbit in 2019. This $2.1B acquisition was closed as…

How Cognoa’s Use Of AI Is Transforming Diagnostic Procedure For Children

Cognoa is a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions. The company announced June 2nd, 2021 that the FDA granted its De Novo classification…

Microsoft Takes A Nuanced Approach to AI Healthcare

Artificial intelligence has become an invaluable tool in neuroscience due to its ability to vastly improve our understanding of the human brain, and therefore make us better equipped to diagnose and treat neurological disorders. Emerging…

Patent Forecast® gives you AI-driven, interactive data that identifies key innovators and first movers.

Includes interactive Patent Radian, real-time USPTO updates, and market insights.

TRY IT FREE FOR 7 DAYS